TT-00434

N/A

Report date: 2023/12/08 13:55:39

NME

Base Information

Drug NameTT-00434

Drug Alias NameTT-00434

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 1 antagonistsFibroblast growth factor receptor 2 antagonistsFibroblast growth factor receptor 3 antagonists

TargetsFibroblast growth factor receptor 1Fibroblast growth factor receptor 2Fibroblast growth factor receptor 3

Therapy Area/IndicationsSolid tumoursUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwanMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesTransThera Sciences (Nanjing) Inc

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTransThera Sciences (Nanjing) Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursUrinary Bladder Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A